Anthem Biosciences Limited (ANTHEM) — Board Meeting

· NSE 🟡 Notable Neutral

Anthem Biosciences Limited announced its 20th Annual General Meeting on July 22, 2026, via video conference, with e-voting open from July 19 to 21. Shareholders approved a ₹2 dividend per share, reappointment of auditor S.R. Batliboi & Associates LLP for five years at [amount not verified], and continued independent director Ravikant Uppal until 2029. Remuneration for related party employees Ishaan Bhardwaj (H 15M), Krithika Ganesh (H 3.75M), and Keerthana Ravindra (H 3.35M) was approved despite exceeding Section 188 thresholds. The Board also seeks approval for an upside sharing arrangement with Viridity Tone LLP, linking investor payouts to promoter share sales.

📄 View Original Announcement (PDF)

About Anthem Biosciences Limited (ANTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹43,999.05 Cr P/E: 109.4

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

📊 More ANTHEM filings

See all ANTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day